Company · CIK 0001814114 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
Orchestra BioMed Holdings, Inc. · OBIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 FForm 4 → | Sep 11, 6:11 pm EDT | David P HochmanSee Remarks, Director | 6,566 | $5.81 | $38,148 | 432,916 | — | |
| Sep 3, 2026 PForm 4 → | Sep 8, 8:15 am EDT | David P HochmanSee Remarks, Director | 10,000 | $4.79 | $47,900 | 1,070,746 | +0.94% | |
| Sep 1, 2026 SForm 4 → | Sep 2, 4:15 pm EDT | Darren ShermanSee Remarks, Director | 15,000 | $4.94 | $74,100 | 1,134,402 | −1.31% | 10b5-1 |
| Aug 26, 2026 FForm 4 → | Aug 28, 4:16 pm EDT | Andrew Lawrence TaylorChief Financial Officer | 3,076 | $5.26 | $16,180 | 589,989 | — | |
| Aug 26, 2026 PForm 4 → | Aug 28, 4:15 pm EDT | Darren ShermanSee Remarks, Director | 2,000 | $5.33 | $10,660 | 2,000 | — | |
| Aug 26, 2026 FForm 4 → | Aug 28, 4:15 pm EDT | Darren ShermanSee Remarks, Director | 4,925 | $5.26 | $25,906 | 1,149,402 | — | |
| Aug 26, 2026 FForm 4 → | Aug 28, 4:15 pm EDT | Joshua AielloPrincipal Accounting Officer | 203 | $5.26 | $1,068 | 18,441 | — | |
| Aug 12, 2026 FForm 4 → | Aug 14, 4:17 pm EDT | David PacittiDirector | 3,761 | $4.42 | $16,624 | 54,750 | — | |
| Aug 12, 2026 FForm 4 → | Aug 14, 4:16 pm EDT | Eric S FainDirector | 5,145 | $4.42 | $22,741 | 99,630 | — | |
| Aug 12, 2026 FForm 4 → | Aug 14, 4:15 pm EDT | John Prosper MackDirector | 4,885 | $4.42 | $21,592 | 66,544 | — | |
| Aug 12, 2026 FForm 4 → | Aug 14, 4:15 pm EDT | Chris ClearyDirector | 4,238 | $4.42 | $18,732 | 29,153 | — | |
| Aug 3, 2026 SForm 4 → | Aug 4, 4:49 pm EDT | Darren ShermanSee Remarks, Director | 15,000 | $4.09 | $61,350 | 1,154,327 | −1.28% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 4:15 pm EDT | Darren ShermanSee Remarks, Director | 15,000 | $4.27 | $64,050 | 1,169,327 | −1.27% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.